Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Iconovo ABOSTO:ICO -0.92%34 Gross Margin % is 331.26% as of Mar. 2026, which is 161% above its 10-year median of 127.05. GuruFocus rates OSTO:ICO with a GF Score™ of 34/100 and a GF Value™ of kr0.27 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Iconovo AB ranks better than 99.75% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Iconovo AB's Gross Profit for the
three
months ended in Mar. 2026 was kr2.24 Mil. Iconovo AB's Revenue for the
three
months ended in Mar. 2026 was kr0.68 Mil. Therefore, Iconovo AB's Gross Margin % for the quarter that ended in Mar. 2026 was 331.26%.
The historical rank and industry rank for Iconovo AB's Gross Margin % or its related term are showing as below:
OSTO:ICO'
s Gross Margin % Range Over the Past 10 Years
Min: 99.69 Med: 127.05 Max: 1042.35
Current: 745.01
During the past 10 years, the highestGross Margin % of Iconovo AB was 1042.35%. The lowest was 99.69%. And the median was 127.05%.
OSTO:ICO's Gross Margin % is ranked better than 99.75% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.05
vs OSTO:ICO: 745.01
Iconovo AB had a gross margin of 331.26% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Iconovo AB was 60.20% per year.
Iconovo AB (OSTO:ICO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Iconovo AB had a gross margin of 331.26% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Iconovo AB Gross Margin % Related Terms
Iconovo AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Iconovo AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ICO vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Iconovo AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iconovo AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Iconovo AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Iconovo AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Iconovo AB (OSTO:ICO) has a Gross Margin % of 331.26% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Iconovo AB and its competitors. This is 161% above median its historical median of 127.05. Over the past decade, Iconovo AB's Gross Margin % has ranged from 99.69 to 1,042.35. According to the industry distribution chart, Iconovo AB ranks #2 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 0.2%.
Is Iconovo AB's Gross Margin % too high?
Iconovo AB's current Gross Margin % of 331.26% is 161% above median its 10-year median of 127.05. Over the past 10 years, this metric has ranged from a low of 99.69 to a high of 1,042.35. The Medical Devices & Instruments industry median Gross Margin % is 52.05. Iconovo AB's value of 331.26% is 536.4% above this industry median. Based on the distribution chart, Iconovo AB ranks #2 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Iconovo AB has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Iconovo AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Iconovo AB ranks #2 out of 806 companies for Gross Margin %. This places Iconovo AB in the top 0% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.05. Iconovo AB's value of 331.26% is 536.4% above this benchmark. Historically, Iconovo AB's own Gross Margin % has ranged from 99.69 to 1,042.35 over the past decade. While the company's 10-year median is 127.05 vs. the industry median of 52.05, Iconovo AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.05, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Iconovo AB's current Gross Margin % of 331.26% is 536.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Iconovo AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Iconovo AB's current Gross Margin % is 331.26%, which is 161% above median its own 10-year median of 127.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iconovo AB stock overvalued right now?
Based on GuruFocus' analysis, Iconovo AB (OSTO:ICO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.27, compared to a current price of kr1.08 — trading 300% above its estimated fair value. The current Gross Margin % is 331.26%, which is 161% above median its 10-year median of 127.05 and 536.4% above the Medical Devices & Instruments industry median of 52.05. Iconovo AB's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Iconovo AB (OSTO:ICO), the current Gross Margin % is 331.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Iconovo AB (OSTO:ICO) Overvalued in 2026?
Based on GuruFocus' analysis, Iconovo AB stock appears to be overvalued.
The current stock price of kr1.08 is trading 300% above its estimated GF Value™ of kr0.27.
GuruFocus considers Iconovo AB to be Significantly Overvalued.
Key valuation signals for OSTO:ICO:
Gross Margin %: 331.26% (161% above median its 10-year median of 127.05)
GF Value™: kr0.27 vs. price of kr1.08 (300% above fair value)
Industry Position: 536.4% above the Medical Devices & Instruments median (#2 of 806)
No single metric tells the full story. See the OSTO:ICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.
34GF Score
Get the complete analysis for OSTO:ICO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ICO has been successfully added to your 
